Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms

Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are by far the most advanced radiopharmaceuticals for diagnosis and therapy (radiotheranostics) of NENs. Their clinical success emerged receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Fani, Melpomeni, Kolenc Peitl, Petra, Velikyan, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374434/
https://www.ncbi.nlm.nih.gov/pubmed/28295000
http://dx.doi.org/10.3390/ph10010030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374434/
https://www.ncbi.nlm.nih.gov/pubmed/28295000
http://dx.doi.org/10.3390/ph10010030

Ejemplares similares